AgingResearch.NewsJoin free

Icope screening tool

Icope screening tool has been studied in 2 papers since 2022: 2 observational studies in people. The newest paper, Aug 23, 2023: “Diagnostic performance analysis of the Integrated Care for Older People (ICOPE) screening tool for identifying decline in intrinsic capacity”.

Exposure

2 papers study it3 findingsUpdated

“ICOPE Screening tool sensitivity was higher for cognition (0.889) and ranged between 0.438 and 0.569 for most domains.”
Identification of decreased intrinsic capacity: Diagnostic performance indicators of the ICOPE Screening tool in community-dwelling older people in the VIMCI studyResearch Square2022doi:10.21203/rs.3.rs-2175722/v1

None of its findings points the other way.

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

  • 2 independent labs in 2 countries
  • Funders: European Commission and 4 more
  • Humans2

What is Icope screening tool linked with?

3

Studies link Icope screening tool with 3 measures, most often intrinsic capacity decline (1 study), Diagnostic accuracy for intrinsic capacity decline (1) and Diagnostic sensitivity for intrinsic capacity decline (1).

Intrinsic capacity decline

upin humans1

1 study

  1. Icope screening tool predicts intrinsic capacity decline in humans (AUC 0.91 (95% CI: 0.87-0.95, p = 0.020)).

    “The diagnostic effectiveness of the ICOPE screening tool was 0.91 (95% confidence interval: 0.87-0.95, p = 0.020).”

    Humanscommunity-dwelling older peoplen = 228

    Diagnostic performance analysis of the Integrated Care for Older People (ICOPE) screening tool for identifying decline in intrinsic capacity

    BMC geriatrics

Diagnostic accuracy for intrinsic capacity decline

upin humans1

1 study

  1. Icope screening tool is associated with diagnostic accuracy for intrinsic capacity decline in humans (specificity 0.682 to 0.96, diagnostic accuracy 0.627 to 0.879).

    “Specificity ranged from 0.682 to 0.96, diagnostic accuracy from 0.627 to 0.879, Youden index from 0.12 to 0.619, and Gwet AC1 from 0.275 to 0.842”

    Humanscommunity dwelling persons ≥ 70-year-old with Barthel ≥ 90, without dementia or advanced chronic conditionsn = 207

    Identification of decreased intrinsic capacity: Diagnostic performance indicators of the ICOPE Screening tool in community-dwelling older people in the VIMCI study

    Research SquarePreprint

Diagnostic sensitivity for intrinsic capacity decline

upin humans1

1 study

  1. Icope screening tool is associated with diagnostic sensitivity for intrinsic capacity decline in humans (sensitivity 0.889 (cognition), 0.438 to 0.569 (most domains)).

    “ICOPE Screening tool sensitivity was higher for cognition (0.889) and ranged between 0.438 and 0.569 for most domains.”

    Humanscommunity dwelling persons ≥ 70-year-old with Barthel ≥ 90, without dementia or advanced chronic conditionsn = 207

    Identification of decreased intrinsic capacity: Diagnostic performance indicators of the ICOPE Screening tool in community-dwelling older people in the VIMCI study

    Research SquarePreprint

Latest

Related